Market Definition:

Neuroendocrine tumors (NETs) emerge from hormone-producing cells of body’s neuroendocrine system and nervous system. NETs tend to release higher-than-normal amounts of hormones and impact negatively the important body organs such as the lungs, gastrointestinal tract, stomach and intestines and various body functions. These tumors may be benign or malignant in nature. Some examples of neuroendocrine tumors are carcinoid tumors, islet cell tumors, medullary thyroid cancer, pheochromocytomas, neuroendocrine carcinoma of the skin (Merkel cell cancer), small cell lung cancer, and large cell neuroendocrine carcinoma (a rare type of lung cancer). The tumors begins with infecting the intestine and form carcinoid tumors, followed by pancreas.

NETs can infect a range of glands such as thymus, thyroid, adrenal and pituitary gland. Efficient treatment for neuroendocrine tumor is extremely necessary because if the tumor is malignant in nature; it might spread to nearby tissues or lymph nodes, eventually spreading throughout the body. The treatment options for NETs are limited in number and include surgical removal of tumors, chemotherapy, targeted therapy and radiation therapy, etc. There is no standard treatment for treating neuroendocrine tumor but two novel targeted therapy drugs- Afinitor and Sutent have been approved by FDA for treatment of advanced pancreatic neuroendocrine tumors and is beneficial for some patients according to the type and severity of the indication.

Get PDF with Technological trends at https://www.xpodenceresearch.com/Request-Sample/106914

Market Analysis with Latest Growth Factors:

Globally, increasing incidences of NET among patients mainly due to disorders such as Multiple endocrine neoplasia type 1 (MEN1), Multiple endocrine neoplasia type 2 (MEN2), Neurofibromatosis type 1 (NF1), Von Hippel-Lindau syndrome (VHL) and Tuberous sclerosis complex (TSC) disease. However, in October, 2017, JAMA Oncology Journal published an article stating that the survival rate for all Neuroendocrine Tumor Treatment Market has improved, especially for distant-stage gastrointestinal Neuroendocrine Tumor Treatment Market and pancreatic Neuroendocrine Tumor Treatment Market. This is attributed to availability of better therapies and early detection and diagnosis techniques. Thus, introduction of new therapies and extended indications for approved drugs is expected to augment NET treatment industry. Targeted therapy is one of the most preferred methods to treat neuroendocrine tumor. Such innovative and highly effective approach for treating cancers is also responsible for gaining traction during the forecast period.

Increasing adoption of advanced diagnostic imaging techniques such as endoscopic ultrasonography etc. would result in discovery of NETs which are small in size and are relatively clinically insignificant. These kind of tumors are not related to the symptoms and may not require surgical excision and hence, requiring other techniques for treating the tumor, resulting in fueling the market.

Major Key Players:

Some of the key players of NET treatment market are Advanced Accelerator Applications, Novartis AG, Hutchison Medipharma Limited, Dauntless Pharmaceuticals Inc., Ispen, Tarveda Therapeutics, Exelixis, Inc., Pfizer Inc, and Progenics Pharmaceuticals, Inc

Market Segmentation:

The neuroendocrine treatment market is segmented on the basis of drug, indication, end user and geography. Based on drug, the NET market is categorized into Everolimus, Sunitinib Malate, Lu-Dotate, Lanreotide, and Octreotide. On the basis of indication, the segment is bifurcated into gastrointestinal neuroendocrine tumor, lung neuroendocrine tumor, pancreatic neuroendocrine tumor and others neuroendocrine Tumor. Whereas, hospitals, oncology centers, and others including GI centers, cardio-thoracic centers, NET centers are few end users in this industry. Geographically, the NET treatment market is bifurcated into North America, Europe, Asia Pacific, Middle East &Africa and Latin America.

Obtain Report Details with technological advancement at https://www.xpodenceresearch.com/Reports/Neuroendocrine-Tumor-Treatment-Market

Region Analysis:

The North America region is expected to dominate the neuroendocrine tumor treatment market during the forecast period owing to the establishment of various national universities and small scale pharmaceutical companies researching and developing effective drug for NET, capable of modifying clinical approach to treat neuroendocrine tumors. Thus, pharmaceutical and biotechnology companies have a major opportunity to progress in the U.S. NET treatment industry.

Major Points from Table of content:

Executive Summary
Research Methodology
Market Dynamics
Industry Overview
Global Neuroendocrine Tumor Treatment Market, By Product (2017-2025)
Global Neuroendocrine Tumor Treatment Market, By Regions (2017-2025)
Market Competition Analysis
About Us:

Xpodence Research have the most extensive collection of market research reports of many categories. Xpodence Research provides the best market research solution for every industry by publishing the best possible results of great market research firms worldwide. For every particular problem, there’s a particular solution, so according to the customer needs, we provide the best possible results to them from different market research organization, whether it’s a Custom Research or Syndicated Research reports because the product that wins is the one that bridges customers to the future, not the one that requires a giant leap.

Every organization, whether it is related to Pharmaceuticals, Technology, Eatables, Consumable Goods and many more demands a market research results so that they can take important decisions for more productivity and better output in this swift world. Xpodence Research gives the best possible outcome, perfect forecast, analysis and insights of market research in the form of report which is beneficial for various organizations and also to the manufacturing companies in taking the best decisions for quality production.

Contact Us:

Xpodence Research

244, Madison Avenue

New York City, NY - 10016

United States

Toll Free +1- 844-445-2861

Email: [email protected]